XFOR logo

X4 Pharmaceuticals (XFOR) Long Term Debt

Annual Long Term Debt

$57.18 M
+$21.27 M+59.25%

December 31, 2023


Summary


Performance

XFOR Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXFORbalance sheetmetrics:

Quarterly Long Term Debt

$76.98 M
-$75.00 K-0.10%

September 30, 2024


Summary


Performance

XFOR Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXFORbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

XFOR Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+59.3%-0.1%
3 y3 years+51.8%-0.1%
5 y5 years+624.4%+247.8%

XFOR Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+59.3%-0.1%+241.7%
5 y5-yearat high+159.7%-0.1%+249.7%
alltimeall timeat high+1115.6%-0.1%+899.0%

X4 Pharmaceuticals Long Term Debt History

DateAnnualQuarterly
Sep 2024
-
$76.98 M(-0.1%)
Jun 2024
-
$77.06 M(+34.9%)
Mar 2024
-
$57.14 M(-0.1%)
Dec 2023
$57.18 M(+59.3%)
$57.18 M(+0.0%)
Sep 2023
-
$57.17 M(+63.5%)
Jun 2023
-
$34.96 M(-0.7%)
Mar 2023
-
$35.20 M(-2.0%)
Dec 2022
$35.91 M(-5.3%)
$35.91 M(+59.4%)
Sep 2022
-
$22.53 M(-21.3%)
Jun 2022
-
$28.63 M(-16.5%)
Mar 2022
-
$34.29 M(-9.6%)
Dec 2021
$37.91 M(+0.7%)
$37.91 M(-0.5%)
Sep 2021
-
$38.11 M(-2.0%)
Jun 2021
-
$38.89 M(-0.1%)
Mar 2021
-
$38.94 M(+3.4%)
DateAnnualQuarterly
Dec 2020
$37.66 M(+71.1%)
$37.66 M(+24.7%)
Sep 2020
-
$30.21 M(+12.6%)
Jun 2020
-
$26.84 M(-0.4%)
Mar 2020
-
$26.95 M(+22.4%)
Dec 2019
$22.02 M(+178.9%)
$22.02 M(-0.5%)
Sep 2019
-
$22.13 M(-8.2%)
Jun 2019
-
$24.12 M(+44.9%)
Mar 2019
-
$16.64 M(+110.8%)
Dec 2018
$7.89 M(-20.4%)
$7.89 M(+0.9%)
Sep 2018
-
$7.83 M(+1.6%)
Jun 2018
-
$7.71 M(-20.5%)
Mar 2018
-
$9.70 M(-2.3%)
Dec 2017
$9.92 M(-2.0%)
$9.92 M(-2.8%)
Sep 2017
-
$10.21 M(+0.8%)
Dec 2016
$10.13 M(+115.3%)
$10.13 M
Dec 2015
$4.70 M
-

FAQ

  • What is X4 Pharmaceuticals annual long term debt?
  • What is the all time high annual long term debt for X4 Pharmaceuticals?
  • What is X4 Pharmaceuticals annual long term debt year-on-year change?
  • What is X4 Pharmaceuticals quarterly long term debt?
  • What is the all time high quarterly long term debt for X4 Pharmaceuticals?
  • What is X4 Pharmaceuticals quarterly long term debt year-on-year change?

What is X4 Pharmaceuticals annual long term debt?

The current annual long term debt of XFOR is $57.18 M

What is the all time high annual long term debt for X4 Pharmaceuticals?

X4 Pharmaceuticals all-time high annual long term debt is $57.18 M

What is X4 Pharmaceuticals annual long term debt year-on-year change?

Over the past year, XFOR annual long term debt has changed by +$21.27 M (+59.25%)

What is X4 Pharmaceuticals quarterly long term debt?

The current quarterly long term debt of XFOR is $76.98 M

What is the all time high quarterly long term debt for X4 Pharmaceuticals?

X4 Pharmaceuticals all-time high quarterly long term debt is $77.06 M

What is X4 Pharmaceuticals quarterly long term debt year-on-year change?

Over the past year, XFOR quarterly long term debt has changed by -$75.00 K (-0.10%)